Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care
Canadian Journal of Cardiology2017Vol. 33(8), pp. 1036–1043
Citations Over TimeTop 10% of 2017 papers
Markus Gulilat, Anthony Tang, Steven E. Gryn, Peter Leong‐Sit, Allan C. Skanes, Jeffrey Alfonsi, George K. Dresser, Sara Henderson, Rhiannon V. Rose, Daniel J. Lizotte, Wendy A. Teft, Ute I. Schwarz, Rommel G. Tirona, Richard B. Kim
Related Papers
- → Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH Calibrator(2018)42 cited
- → Using New Oral Anticoagulants in Patients Undergoing Major Orthopedic Surgery(2015)5 cited
- A new strategy for uncontrollable bleeding after treatment with rivaroxaban or apixaban.(2019)
- → The effects of direct oral anticoagulants apixaban and rivaroxaban on haemostasis tests(2015)1 cited
- → ▼ Apixaban and ▼ rivaroxaban for stroke prevention in AF(2014)1 cited